XTalks

AUGUST 13, 2020

As the rush for a COVID-19 vaccine continues, healthcare services company Kaiser Permanente has joined in on the clinical testing of Pfizer Inc. and BioNTech’s lead vaccine candidate in a Phase III trial being conducted at sites in California and Oregon.

Vaccination 89

Vaccination Vaccine Trials Clinical Trials 89

DM Clinical Research

JULY 30, 2021

Once you are fully vaccinated, it is safe to do many of the things you used to enjoy before lockdown. Naturally, you might be wondering: Can I get my second COVID vaccine early? Is there any way to speed up the vaccination process? Read on to learn about the safest- and most effective- way to get your COVID vaccine doses.

Vaccination 40

Vaccination Vaccine Immune Response Doctors 40

The Pharma Data

MARCH 31, 2022

A Phase 2 clinical trial evaluating various additional COVID-19 booster shots has begun enrolling adult participants in the United States. “This trial will help us understand if we can use prototype and variant vaccines alone or together to shift immune responses to cover existing and emerging COVID-19 variants.”

Clinical Trials 52

Clinical Trials Clinical Trials Trials Immune Response 52

Pfizer

FEBRUARY 16, 2023

who had been enrolled in the Vaccine Against Lyme for Outdoor Recreationists (VALOR) (NCT05477524) Phase 3 clinical study. The study is investigating the efficacy, safety and immunogenicity of an investigational Lyme disease vaccine candidate, VLA15.

Clinical Trials 76

Clinical Trials Clinical Trials Vaccination Vaccine 76

pharmaphorum

FEBRUARY 18, 2021

The aim of the study is to find the smallest amount of SARS-CoV-2 that is needed to cause an infection, see how the immune system reacts to the virus, and to assist in the development of new treatments and vaccines. Dr Chris Chiu. The study was first announced last year in a media briefing at the Wellcome Trust in London.

Vaccination 107

Vaccination Vaccine Immune Response Trials 107

pharmaphorum

APRIL 27, 2021

Following the success of the coronavirus vaccine developed with AstraZeneca, Oxford University’s Jenner Institute has unveiled trial results showing its experimental malaria shot could be around 77% effective. Vaccine efficacy was 74% and 77% in the low and high dose adjuvant group, respectively.

Vaccination 52

Vaccination Vaccine Immune Response Trials 52

pharmaphorum

JULY 7, 2022

In the second of a three-part series, Ben Hargreaves looks at the importance of early-stage research into various emerging infectious disease threats and how it saved precious time in the work to develop a working vaccine during the current pandemic. Building blocks. Identifying the threat.

Vaccination 98

Vaccination Vaccine Development Research 98

STAT News

MARCH 6, 2023

Still, when doctors told her last year that the cancer was growing despite two operations, radiation therapy, and a fifth regimen of chemotherapy, the retired business-meeting facilitator decided to do something unorthodox: spend $83,000 out of pocket on an unproven experimental cancer vaccine.

Vaccination 98

Vaccination Vaccine Drugs Clinical Trials 98

pharmaphorum

APRIL 4, 2022

After children five and above began to receive the vaccine, doctors found that some kids had vaccine-associated myocarditis (inflammation of the heart muscles) or pericarditis (inflammation of the heart’s outer lining). Promisingly, 76% of the US population has received at least one dose of the COVID-19 vaccine, and 73.5%

Vaccination 109

Vaccination Vaccine Doctors Doctor 109

XTalks

DECEMBER 17, 2021

The year continued to be dominated by COVID-19, and the second year of the pandemic was all about vaccines. And while over 8 billion doses of vaccines have been administered worldwide, billions more are still needed. And while over 8 billion doses of vaccines have been administered worldwide, billions more are still needed.

Life Science 98

Life Science Vaccination Vaccine Trials 98

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

pharmaphorum

AUGUST 27, 2020

The pandemic has changed the situation, highlighting the importance of having a vibrant and strong UK life sciences sector that can provide COVID-19 vaccines, therapies and tests to help society return to work and get the economy back on track. The first is that the development of vaccines is utilising cutting edge technologies.

Vaccination 114

Vaccination Vaccine Life Science Clinical Trials 114

Delveinsight

JANUARY 21, 2021

Gritstone appends COVID-19 to the pipeline with the NIAID-supported vaccine. Gritstone Oncology, the biotech company, working on cancer vaccines based on traditional infectious disease immunology, works on a vaccine against SARS-CoV-2.

Research 52

Research Protein Clinical Trials Clinical Trials 52

Find Me Cure

SEPTEMBER 19, 2019

Gynaecological cancer is not simply cervical cancer as a direct result of HPV and women who have been vaccinated are not necessarily out of the woods. Cervical cancer is the most discussed one out of the 5 with HPV being a huge topic when it comes to STIs prevention and vaccination starting early on. Vaginal and vulvar cancer.

Hormones 52

Hormones Doctors Doctor Vaccination 52

The Pharma Data

DECEMBER 20, 2020

CureVac announced it has enrolled the first volunteer in the pivotal Phase IIb/III trial of its own mRNA vaccine candidate, CVnCoV against COVID-19. The technology used for the CureVac vaccine is similar to that utilized by Pfizer-BioNTech and Moderna. Russia’s Sputnik V COVID-19 vaccine demonstrated 91.4% Here’s a look.

Trials 52

Trials Gene Therapy Vaccination Vaccine 52

XTalks

SEPTEMBER 14, 2020

“Vaccine Nationalism” Could Prove the Undoing of COVID-19 Containment. Tension is mounting as nations big and small jockey around industry to ensure they are first in line to access a vaccine, should one prove to be successful against COVID-19. Moderna’s COVID-19 Vaccine. The price of that prize is incalculable.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92

The Pharma Data

DECEMBER 17, 2020

“This study suggests that maybe we could predict or diagnose depression based on inflammatory scores,” said Samara Huckvale, an undergraduate at Columbia University working in the laboratory of UT Southwestern professor Sherwood Brown, senior author of both papers and professor of psychiatry and vice chair for clinical research at UTSW. “Or

Research 52

Research Gene Clinical Trials Clinical Trials 52

Drug Discovery World

MAY 30, 2023

As the US National Cancer Research Month draws to a close, we asked experts from across the industry “What do you feel has been the most exciting development in cancer research in the last five years?” The post National Cancer Research Month: Celebrating drug discovery innovation appeared first on Drug Discovery World (DDW).

Research 52

Research Drugs Protein RNA 52

Drug Discovery World

APRIL 15, 2023

As such, Codagenix has previously demonstrated that CodaLytic, a codon-modified influenza virus, can kickstart the cancer immunity cycle at various steps in several mouse models with differing baseline immune contextures.

Antibody 52

Antibody Trials Research Gene Editing 52

The Pharma Data

APRIL 4, 2023

Merck has the industry’s largest immuno-oncology clinical research program. The KEYTRUDA clinical program seeks to understand the role of KEYTRUDA across cancers and the factors that may predict a patient’s likelihood of benefitting from treatment with KEYTRUDA, including exploring several different biomarkers.

FDA Approval 40

FDA Approval Containment Hormones Dermatology 40